The FDA has approved a generic form of fluticasone propionate inhalation aerosol (Flovent HFA) as a prophylactic maintenance treatment for asthma, the agency announced on Tuesday.

CGT designations are granted to medicines with limited generic competition, and first‑approved applicants are eligible for ...

Key market opportunities in the inhaler solution market include the rising demand driven by increased respiratory disorders like asthma and COPD, expanding access to medicines in low and middle-income ...

New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are ...

Shares of United Therapeutics climbed after the company said it planned to release a new soft mist inhaler to treat certain lung diseases next year. The stock rose 9%, to $515.94, midday Wednesday and ...

A new study is offering children with asthma an enhanced check-up to see whether it can bring down the overuse of inhalers. The Prescription Alerts for Reliever Inhalers in Children (PARC) study at ...

Add Yahoo as a preferred source to see more of our stories on Google. Are Americans paying nearly $500 for an inhaler that would cost just $7 overseas? U.S. Sen. Tammy Baldwin, D-Wis., says there is a ...

Randomized trial compares valved holding chambers for albuterol inhalation therapy ...

If you rely on a steroid inhaler, make sure you know about this recent study, as one woman details her nightmare health scare, caused by hers. Medicines often come with expected side effects, but when ...

When it comes to questioning drug patents, the U.S. Federal Trade Commission (FTC) isn’t backing down. After filing a challenge in November against more than 100 patents in the FDA’s Orange Book—and ...